BASF has completed the acquisition of Pronova BioPharma ASA, Lysaker, Norway. It actually holds 98.19 % of Pronova shares. The squeeze out is said to be implemented within the next days.
BASF will fully integrate Pronova into its Nutrition & Health division and Pronova will become a key part of BASF’s omega-3-business.
- BASF SE, Ludwigshafen, Germany